Abstract
Abstract
Background
Two decades of research on quality-of-life (QOL) appraisal have demonstrated links between patient experience and health outcomes and have accounted for both intra-individual change and inter-individual differences in a wide range of research contexts. The present work investigates patterns across diagnostic and demographic groupings to demonstrate how population-specific circumstances drive the structure of QOL appraisal.
Methods
This secondary analysis (N = 6448) utilized data from six patient groups: spine surgery, multiple sclerosis, heterogeneous chronically ill, heterogeneous cancer, bladder cancer, and human immunodeficiency virus (HIV). We explored patterns of inter-item correlation across patient samples, using items from the Standards of Comparison and Sampling of Experience subsections of the QOL Appraisal Profile v1 and v2. Similar matrices were compared by demographic characteristics.
Results
Patterns of inter-item correlations for Standards of Comparison items varied sharply across disease groups and racial groups while being similar across age, gender, and education levels. Inter-item correlation matrices for Sampling of Experience items revealed marked differences among disease groups and educational and racial categories but were similar across age and gender groups.
Conclusions
Appraisal parameters showed evidence of shared and unique aspects across samples and circumstances, findings which make sense in light of sample differences in health status and demographic influences. Tools to assess patient experience and meaning may be best understood as idiometric instruments. We discuss their distinctions from psychometric and clinimetric tools at theoretical, statistical, and applied levels.
Publisher
Springer Science and Business Media LLC
Subject
Health Information Management,Health Informatics
Reference56 articles.
1. U.S. Food & Drug Administration (2019). CDER patient-focused drug development https://www.fda.gov/drugs/development-approval-process-drugs/cder-patient-focused-drug-development. Accessed 11 Sep 2019.
2. Rapkin, B. D., & Schwartz, C. E. (2004). Toward a theoretical model of quality-of-life appraisal: Implications of findings from studies of response shift. Health and Quality of Life Outcomes, 2(1), 14.
3. Schwartz, C. E., Michael, W., & Rapkin, B. D. (2017). Resilience to health challenges is related to different ways of thinking: Mediators of quality of life in a heterogeneous rare-disease cohort. Quality of Life Research, 26, 3075–3088. https://doi.org/10.1007/s11136-017-1633-2.
4. Schwartz, C. E., Powell, V. E., & Rapkin, B. D. (2017). When global rating of change contradicts observed change: Examining appraisal processes underlying paradoxical responses over time. Quality of Life Research, 26, 847–857. https://doi.org/10.1007/s11136-016-1414-3.
5. Schwartz, C. E., & Rapkin, B. D. (2004). Reconsidering the psychometrics of quality of life assessment in light of response shift and appraisal. Health and Quality of Life Outcomes, 2, 16.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献